「dry」の検索結果
50件：46～50件目を表示
もしかして
-
maceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan;...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
maceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan;...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
uring and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
uring and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
es surveyed, but the product development theme considers the value of fulfillment. Corneal diseases Dry eye (DE) is a typical corneal disease. Dry eye causes discomfort and abnormal visual function ow...
http://www.senju.co.jp/english/rd/policy/